ALNY vs FER Comparison

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.

Ferrovial SE is a Spanish industrial company. The company organizes itself into four segments: Toll Roads, Airports, Construction, and Energy and mobility infrastructures. The Toll Roads segment develops and operates toll roads globally. The Airports segment operates four airports in the United Kingdom, Heathrow, Aberdeen, Glasgow, and Southampton. The Construction segment designs and constructs buildings, transport infrastructure, water projects, and completes civil engineering work. The Energy and mobility infrastructures segment includes the operation of infrastructure for transport, natural resources, utilities, telecommunications, and waste collection and treatment. By country, the USA represents the maximum contribution to revenue, followed by Poland operations.